Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease
Nina Dominik(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Elena Campello(University of Padua), Peter Quehenberger, Alberto Zanetto(University of Padua), Benedikt Simbrunner(Austrian Academy of Sciences), Paolo Simioni(University of Padua), Bernhard Scheiner(Medical University of Vienna), Matthias Pinter(Medical University of Vienna), Rafael Paternostro(Medical University of Vienna), Georg Semmler(University of Southern Denmark), Thomas Reiberger(ERN GUARD-Heart), Benedikt Hofer(Austrian Academy of Sciences), Albert Friedrich Stättermayer(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Lorenz Balcar(Medical University of Vienna), Michael Schwarz(Medical University of Vienna)
Cited by 24
Related Papers
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k